Search Within

Malin Lisa Hultcrantz

  1. "2018"
Formats
  1. Meeting Abstract (13)
  2. Journal Article (5)
  3. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (19)
  2. Department of Medicine (19)
  3. Hematologic Malignancies, Division of (19)
  4. Myeloma (19)
  5. Sloan Kettering Institute Postdocs (19)
  6. Hematologic Malignancies Research (18)

More Groups

People
  1. Carl Landgren (18)
  2. Neha Korde (8)
  3. Sham Mailankody (8)
  4. Alexander Lesokhin (7)
  5. Heather Landau (7)
  6. Nikoletta Lendvai (7)

More People

Years
  1. 2018 (19)
Publications
  1. Blood (11)
  2. Haematologica (1)
  3. Hematologic Malignancies (1)
  4. JAMA Oncology (1)
  5. Journal of Clinical Oncology (1)
  6. Journal of Molecular Diagnostics (1)

More Publications

Publishers
  1. American Society of Hematology (11)
  2. Springer (2)
  3. American Medical Association (1)
  4. American Society of Clinical Oncology (1)
  5. Elsevier Science, Inc. (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (19)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular underpinnings of clinical disparity patterns in African American (AA) versus Caucasian American (CA) multiple myeloma (MM) patients
    Meeting Abstract

    Hill, E. M.; Kwok, M.; Yellapantula, V.; Hultcrantz, M.; Korde, N.; Mailankody, S.; Papaemmanuil, E.; Maric, I.; Kazandjian, D. G.; Landgren, O.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mastey, D.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Tavitian, E.; Salcedo, M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Mytype: A capture based sequencing approach to detect somatic mutations, copy number changes and IGH translocations in multiple myeloma
    Meeting Abstract

    Yellapantula, V.; Hultcrantz, M.; Rustad, E. H.; Landau, H. J.; Iacobuzio-Donahue, C.; Akhlaghi, T.; Amit, I.; Ledergor, G.; Korde, N.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Whole genome sequencing of extramedullary myeloma autopsy tumors reveals a genomic portrait at culmination of clonal convergence
    Meeting Abstract

    Yellapantula, V. D.; Rustad, E. H.; Glozdik, D.; Gundem, G.; Fan, J.; Medina, J.; Patel, A.; Patel, M.; Hultcrantz, M.; Peled, J. U.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Continuous mobile wearable bio-monitoring of newly diagnosed multiple myeloma patients undergoing initial chemotherapy
    Meeting Abstract

    Tavitian, E.; Mastey, D.; Salcedo, M.; Zarski, A.; Chansakul, A.; Diab, V.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Depth of response and outcomes in patients with multiple myeloma undergoing autologous stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Seier, K.; Devlin, S. M.; Chung, D. J.; Scordo, M.; Hultcrantz, M.; Korde, N.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • V(D)J sequence capture for DNA-based minimal residual disease detection in multiple myeloma
    Meeting Abstract

    Rustad, E. H.; Hultcrantz, M.; Yellapantula, V. D.; Akhlaghi, T.; Ho, C.; Arcila, M. E.; Roshal, M.; Patel, A.; Devlin, S. M.; Jacobsen, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Treatment outcomes in monoclonal immunoglobulin deposition disease (MIDD): A two center experience
    Meeting Abstract

    Pianko, M. J.; Tiutan, T.; Flynn, J.; Devlin, S. M.; Jaffer-Sathick, I.; Rossi, A. C.; Salvatore, S. P.; Landau, H. J.; Lendvai, N.; Smith, E. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Risk factors for acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma: An updated analysis
    Meeting Abstract

    Jonsdottir, G.; Björkholm, M.; Turesson, I.; Hultcrantz, M.; Porwit, A.; Jethava, Y.; Landgren, O.; Kristinsson, S. Y.
    Blood (2018)

    Fulltext@MSK | Save